In this study, researchers evaluated changes in CVD risk factors and 10-year CVD risk from before to after a breast cancer diagnosis, and compared it with women who remained free of such a diagnosis.
Professor Han Liang speaks with Cancer Network about the ubiquitin pathway and its role in cancer research.
A new study evaluated whether busulfan and melphalan improve EFS and OS when given after vincristine, ifosfamide, doxorubicin, and etoposide induction.
Guang Peng, MD, PhD spoke to Cancer Network about the recent discovery that mTORC1 can help determine cell fate after DNA damage.
While becoming pregnant is generally possible for younger breast cancer patients, researchers believe many women change their minds after treatment.
Researchers tested whether 2 years of maintenance therapy with olaparib would improve outcomes in advanced ovarian cancer patients.
Researchers tested whether immunotherapy could be safely used in HIV-positive patients with cancer.
A 73-year-old man presents with neck pain and a mass of possible thyroid origin. What is your diagnosis?
Regular users of low-dose aspirin appear to have a reduced risk of developing ovarian cancer, according to a new study.
Dr. Raghu Kalluri speaks with Cancer Network about the role of exosomes in cancer progression ahead of his presentation at ESMO 2018.
In premenopausal patients with early breast cancer, approximately one-sixth are not adequately adherent to adjuvant endocrine therapy.
A 52-year-old woman presents with nasal congestion and an intranasal mass. What is your diagnosis?
Dr. Luis Diaz spoke with Cancer Network about monitoring for residual disease in colon cancer ahead of his presentation at ESMO 2018.
Dr. Ian Flinn spoke with Cancer Network about incorporating the newest approved therapies for the management of CLL.
Treatment for prostate cancer with external beam radiotherapy was found to be associated with an increased risk for development of bladder cancer when compared with radical prostatectomy.